XR Intestinal Organoid Digestion Solution

Description

Reliable intestinal organoid establishment begins with the recovery of intact, viable intestinal crypts. During conventional intestinal tissue digestion, insufficient dissociation can leave crypts trapped within the mucosa, while excessive enzymatic or mechanical treatment may disrupt crypt architecture and reduce the ability of intestinal stem cell-containing units to initiate new organoids.

XR Organoid Intestinal Digestion Solution is an optimized intestinal tissue digestion solution developed for controlled dissociation of adult or mouse intestinal tissue. The formulation is designed to release structurally intact crypt units from intestinal mucosal tissue while minimizing unnecessary digestion-related stress and damage.

This ready-to-use intestinal crypt isolation solution supports the preparation of small intestinal and colonic crypts for downstream intestinal organoid culture. Under the documented workflow, tissue is digested at 4°C and requires only gentle pipetting after digestion, helping researchers recover crypts suitable for embedding in an appropriate extracellular matrix and culture in a compatible intestinal organoid medium.

Specifications

Features

• Optimized specifically for intestinal tissue digestion and intestinal crypt isolation

• Designed for adult or mouse intestinal tissue sample preparation

• Supports recovery of intact small intestinal and colonic crypt units

• Uses controlled low-temperature digestion to help reduce excessive tissue damage

• Requires only gentle pipetting after the documented digestion step

• Helps preserve crypt structure for downstream intestinal organoid establishment

• Suitable for organoid culture workflows involving crypt extraction, matrix embedding and expansion

• Low-endotoxin formulation filtered through a <0.2 μm process

• Convenient room-temperature storage at 15–25°C

How It Works

Intestinal crypt isolation requires separation of epithelial crypt structures from surrounding mucosal tissue without unnecessarily breaking the recovered units into dispersed single cells. XR Organoid Intestinal Digestion Solution is formulated to support this balance through a controlled intestinal tissue dissociation workflow.

After the intestinal sample has been cleaned and cut into small fragments, the tissue is incubated with the digestion solution at 4°C. Gentle pipetting following digestion helps release crypt structures. The suspension is then filtered and centrifuged to collect the recovered crypt-containing fraction for downstream organoid culture.

Recommended Workflow

1. Clean the intestinal tissue and cut it into approximately 1 mm × 1 mm fragments.
2. Add 10 mL of precooled PBS and agitate the tube to wash the intestinal fragments and remove intestinal contents.
3. Repeat the PBS washing process three times.
4. Add 10 mL of XR Organoid Intestinal Digestion Solution.
5. Digest the tissue on a shaker at 4°C for approximately 25 minutes.
6. Remove the digestion solution after incubation.
7. Add 5 mL of an appropriate termination solution to stop digestion.
8. Gently pipette the digested intestinal fragments using a 5 mL pipette.
9. Filter the tissue suspension through a 70 μm cell strainer.
10. Centrifuge at 300 × g for 5 minutes and remove the supernatant.
11. Process the recovered crypt fraction using the appropriate matrix and intestinal organoid culture medium for the intended workflow.

Performance Data

Small Intestinal and Colonic Crypt Recovery

Under the documented test conditions, intestinal tissue was digested at 4°C for approximately 25–30 minutes. Following gentle pipetting with a 5 mL pipette, crypt structures could be recovered from both small intestinal and colonic tissue samples.

Representative small intestinal crypt and colonic crypt recovery following controlled intestinal tissue digestion.

The recovered crypts showed preserved structural integrity under the evaluated conditions. The product documentation indicates that the isolated crypts can be combined with a corresponding organoid culture medium and matrix to support subsequent intestinal organoid formation.

Applications

XR Organoid Intestinal Digestion Solution is designed for intestinal tissue processing workflows in which the recovery of structurally intact crypt units is required before three-dimensional culture. It can be incorporated into organoid research workflows involving small intestinal or colonic tissue samples.

• Intestinal crypt isolation: Controlled release and collection of crypt structures from intestinal mucosal tissue.

• Small intestinal crypt isolation: Preparation of small intestinal crypts for matrix embedding and organoid initiation.

• Colon crypt isolation: Recovery of colonic crypt structures for colon organoid culture workflows.

• Mouse intestinal organoid culture: Preparation of mouse intestinal tissue before crypt-based organoid establishment.

• Adult intestinal tissue processing: Dissociation of adult intestinal samples for downstream organoid research.

• Intestinal organoid establishment: Sample preparation before crypt embedding in an appropriate extracellular matrix.

• Intestinal organoid expansion: Preparation of newly isolated crypt units for subsequent growth in a compatible culture system.

• Intestinal stem cell research: Recovery of crypt units containing the epithelial stem cell compartment for research applications.

• Three-dimensional intestinal culture: Tissue preparation for 3D intestinal epithelial and organoid models.

• Gastrointestinal disease modeling: Establishment of intestinal organoid cultures for research into epithelial biology and disease mechanisms.

• Drug response research: Generation of intestinal organoid models for laboratory evaluation of experimental treatment responses.

• Regenerative biology research: Study of intestinal epithelial renewal, differentiation and tissue organization using organoid platforms.

Why Use an Intestinal-Specific Digestion Solution?

General-purpose tissue dissociation reagents may not provide the level of control required for intestinal crypt extraction. A digestion condition that is too weak may produce low crypt recovery, while overly aggressive treatment may fragment crypts, increase cellular stress and compromise downstream organoid formation.

XR Organoid Intestinal Digestion Solution is optimized around the specific requirement to separate crypt structures from intestinal mucosa while maintaining their overall architecture. Its low-temperature workflow and limited mechanical handling help researchers standardize a critical early step in intestinal organoid culture.

By combining targeted intestinal tissue dissociation with gentle crypt recovery, the solution is suitable for laboratories seeking a more controlled approach to small intestinal and colon organoid sample preparation.

Factors That Can Affect Crypt Isolation

• Tissue fragment size: Uneven or oversized fragments may digest inconsistently.

• Intestinal region: Small intestinal and colonic tissues may differ in dissociation behavior.

• Sample condition: Collection method, storage time and tissue condition may influence crypt recovery.

• Digestion duration: Insufficient incubation may reduce release, while excessive digestion may damage crypt structures.

• Mechanical force: Vigorous or repeated pipetting may disrupt intact crypts.

• Temperature control: The documented workflow uses digestion at 4°C and should not be assumed to perform identically at other temperatures.

• Downstream culture system: Organoid formation also depends on matrix selection, culture medium, seeding density and sample quality.

FAQ

For Research Use Only. Not for use in diagnostic or therapeutic procedures.